A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | CLRB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $22.4 | $282.4 | 10% |
|
| Shares Out (Mil) | 12.2 | 54.0 | 23% |
|
| Institutional Ownership | 95.7% | 93.1% | 68% |
|
| Float (Mil) | 9.3 | 42.2 | 18% |
|
| Beta | 0.55 | 0.94 | 32% |
|
| Avg Daily Volume (000s) | 30 | 482 | 24% |
|
| Price Change (52-week) |
(52.4%) | 59.9% | 14% |
|
| Growth | CLRB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | (7.6%) | (10.1%) | 31% |
|
| EPS (5yr) | 48.4% | 15.9% | 92 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (14.9%) | (15.6%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | ($0.558) | ($2.433) | ($1.915) | |
| Month Ago EPS | ($0.445) | ($2.170) | ($1.788) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.427) | ($2.047) | ($1.603) | |
| Year/Year Chg | (2.1%) | (70.9%) | (93.2%) | |
| Financials | CLRB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($22) | ($43) | 23% |
|
| EPS (TTM) | ($3.751) | ($1.500) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | ($20) | ($31) | 15% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $2 | $4 | 19% |
|
| Enterprise Value (Q1) (Mil) | ($8) | $190 | 2% |
|
| Valuation | CLRB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.65 | 2.84 | 11% |
|
| P/E | na | 20.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | CLRB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (74.2%) | na |
|
| ROA | (88.7%) | (47.7%) | 6% |
|
| ROE | (126.0%) | (55.0%) | 7% |
|
| Liabilities to Assets | 18.5% | 29.8% | 12% |
|
| F-Score | 3 | 3 | 18% |
|
Cellectar Biosciences, Inc. did not pass any screens on 9/4/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
